BioCentury
ARTICLE | Clinical News

Pfizer preclinical data

May 11, 2009 7:00 AM UTC

PF-3845 selectively inhibited fatty acid amide hydrolase (FAAH), raised brain anandamide levels for up to 24 hours and significantly reduced cannabinoid receptor-dependent inflammatory pain in rats. ...